Cenerimod is an investigational new drug that is being evaluated for the treatment of systemic lupus erythematosus.

[1] It is a sphingosine-1-phosphate receptor modulator.

[2] This pharmacology-related article is a stub.

You can help Wikipedia by expanding it.